Takeda’s Dengue Vaccine Met Phase 3 Goals - PrecisionVaccinations
Takeda’s Dengue Vaccine Met Phase 3 Goals PrecisionVaccinations
The pivotal Phase 3 clinical trial of dengue vaccine candidate TAK-003 was reported to have met the primary efficacy endpoint. This is important news since ...
Comments
Post a Comment